“Roche Canada is committed to meeting the current and future healthcare needs of Canadians by providing better care, faster. In partnership with CHU de Québec and CATALIS on the pionERA clinical trial, we recruited the world’s first and second patients with ER-positive and HER2-negative advanced breast cancer. By leveraging the FAST TRACK Evaluation Service, we accelerated the clinical trial start-up, showcasing Quebec’s exceptional leadership and making it a top location in Canada for clinical trials. It’s through collaboration and action like this that we aim to deliver life-changing medicines to patients rapidly and efficiently – reducing the burden of illness.”
